Pacific Biosciences of California (PACB) News Today $1.64 +0.04 (+2.50%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Should You Sell?Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Should You Sell?January 16, 2025 | marketbeat.comBarclays PLC Has $1.01 Million Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Barclays PLC lifted its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 143.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 595,150 shares of the biotechnology company's stoJanuary 15, 2025 | marketbeat.comPacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease DiagnosticsJanuary 14, 2025 | globenewswire.comPacBio Announces Preliminary Fourth Quarter and Full Year RevenueJanuary 14, 2025 | globenewswire.comAnalysts Conflicted on These Healthcare Names: Pacific Biosciences (PACB) and Pharvaris (PHVS)January 13, 2025 | markets.businessinsider.comPacific Biosciences (PACB) Receives a Hold from Morgan StanleyJanuary 13, 2025 | markets.businessinsider.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $69,842.15 in StockJanuary 13, 2025 | americanbankingnews.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Oene Mark Van Sells 34,405 SharesJanuary 11, 2025 | insidertrades.comStockNews.com Upgrades Pacific Biosciences of California (NASDAQ:PACB) to "Sell"January 11, 2025 | americanbankingnews.comInsider Selling: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells 34,405 Shares of StockPacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Oene Mark Van sold 34,405 shares of the company's stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $2.03, for a total transaction of $69,842.15. Following the completion of the sale, the insider now directly owns 1,597,454 shares of the company's stock, valued at $3,242,831.62. The trade was a 2.11 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.January 10, 2025 | marketbeat.comBernstein Sticks to Its Buy Rating for Pacific Biosciences (PACB)January 10, 2025 | markets.businessinsider.comPacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi SequencingJanuary 10, 2025 | globenewswire.comPacific Biosciences of California (NASDAQ:PACB) Upgraded to Sell at StockNews.comStockNews.com upgraded Pacific Biosciences of California to a "sell" rating in a research report on Thursday.January 9, 2025 | marketbeat.comCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtJanuary 7, 2025 | fool.comPacific Biosciences of California (NASDAQ:PACB) Trading 7.2% Higher - Here's What HappenedPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 7.2% - Should You Buy?January 3, 2025 | marketbeat.comPacific Biosciences of California Target of Unusually Large Options Trading (NASDAQ:PACB)Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) saw unusually large options trading activity on Friday. Traders purchased 10,843 call options on the stock. This represents an increase of approximately 193% compared to the average volume of 3,699 call options.January 3, 2025 | marketbeat.comPacBio to Present at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | globenewswire.comBarclays PLC Has $1.01 Million Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Barclays PLC increased its stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 143.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 595,150 shares of the biotechnoDecember 31, 2024 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Rating of "Moderate Buy" by AnalystsPacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) has received an average rating of "Moderate Buy" from the twelve brokerages that are covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a hold recommendation and six have issued a buy rDecember 29, 2024 | marketbeat.comState Street Corp Has $10.67 Million Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)State Street Corp grew its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 5.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,276,156 shares of the biotechnology comDecember 27, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Here's What HappenedPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Here's What HappenedDecember 26, 2024 | marketbeat.comFmr LLC Raises Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Fmr LLC increased its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 641.3% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 408,151 shares of the biotechnology company's stock after buying an additDecember 18, 2024 | marketbeat.comWhy Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short SellersDecember 11, 2024 | msn.comBNP Paribas Financial Markets Has $1.13 Million Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB)BNP Paribas Financial Markets lowered its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 34.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 662,728 shares of the biotechnology company's stock after selling 341,387 shaDecember 11, 2024 | marketbeat.comPacific Biosciences Appoints CEO as Interim CFODecember 6, 2024 | tipranks.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Up - What's Next?Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up - Still a Buy?December 6, 2024 | marketbeat.comSoros Fund Management LLC Raises Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Soros Fund Management LLC raised its stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 23.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2December 6, 2024 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Rating of "Hold" by AnalystsShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have earned an average recommendation of "Hold" from the fifteen research firms that are presently covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a hold rating and seven hDecember 4, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Trading 7.4% Higher - Time to Buy?Pacific Biosciences of California (NASDAQ:PACB) Shares Up 7.4% - What's Next?November 29, 2024 | marketbeat.comSOFTBANK GROUP CORP. Acquires Significant Stake in Pacific Biosciences of California IncNovember 26, 2024 | gurufocus.comSenvest Management LLC Has $1.86 Million Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Senvest Management LLC grew its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 36.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,093,9November 24, 2024 | marketbeat.comPacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right NowNovember 20, 2024 | msn.comDeciphering Disruption: Inside Cathie Wood's Latest Plays (PACB)Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.November 18, 2024 | marketbeat.comSumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Sumitomo Mitsui Trust Group Inc. lessened its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 6.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,865,766 shares of the biotechnolNovember 18, 2024 | marketbeat.comFY2024 EPS Estimates for PACB Lowered by Cantor FitzgeraldPacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2024 EPS estimates for Pacific Biosciences of California in a report released on Wednesday, November 13th. Cantor Fitzgerald analyst R. Osborn now anticipates that theNovember 18, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by UBS GroupUBS Group upgraded Pacific Biosciences of California to a "hold" rating in a report on Sunday.November 14, 2024 | marketbeat.comPacific Biosciences' Cost Cuts Won't Offset Rising CompetitionNovember 12, 2024 | seekingalpha.comPacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 12, 2024 | finance.yahoo.comCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtNovember 12, 2024 | fool.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.3% After Analyst UpgradePacific Biosciences of California (NASDAQ:PACB) Trading Up 5.3% on Analyst UpgradeNovember 12, 2024 | marketbeat.comUBS Downgrades Pacific Biosciences of California (PACB)November 12, 2024 | msn.comScotiabank Keeps Their Buy Rating on Pacific Biosciences (PACB)November 12, 2024 | markets.businessinsider.comScotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $6.00Scotiabank lowered their target price on Pacific Biosciences of California from $7.00 to $6.00 and set a "sector outperform" rating on the stock in a research report on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California Target of Unusually High Options Trading (NASDAQ:PACB)Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) saw unusually large options trading on Monday. Investors purchased 10,101 call options on the stock. This represents an increase of 271% compared to the average daily volume of 2,719 call options.November 11, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Rating Lowered to "Neutral" at UBS GroupUBS Group cut Pacific Biosciences of California from a "buy" rating to a "neutral" rating in a research note on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Given New $2.50 Price Target at Piper SandlerPiper Sandler raised their target price on Pacific Biosciences of California from $2.00 to $2.50 and gave the company a "neutral" rating in a research note on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendatNovember 9, 2024 | marketbeat.comBarclays Reaffirms Their Hold Rating on Pacific Biosciences (PACB)November 8, 2024 | markets.businessinsider.comPacBio to Present at Upcoming Investor ConferencesNovember 8, 2024 | globenewswire.com Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address PACB Media Mentions By Week PACB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PACB News Sentiment▼0.320.44▲Average Medical News Sentiment PACB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PACB Articles This Week▼64▲PACB Articles Average Week Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HBIO News Today TMO News Today A News Today MTD News Today WAT News Today ILMN News Today TECH News Today BIO News Today BRKR News Today CRL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PACB) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
